We have observed
13 EP applications
Peter James Ruscoe
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after April 26, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Stable pharmaceutical composition comprising solifenacin, and method for preparing the same
QUINAZOLINE BASED RESPIRATORY SYNCYTIAL VIRUS INHIBITORS
METHOD FOR PURIFYING DARBEPOETIN ALFA
MICROORGANISM PRODUCING L-METHIONINE PRECURSOR AND THE METHOD OF PRODUCING L-METHIONINE PRECURSOR USING THE MICROORGANISM
SOLID PREPARATIONS CONTAINING PELARGONIUM SIDOIDES EXTRACTS AND SILICIC ACID COMPOUND, AND PREPARING METHOD THEREOF
COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING CNS NEUROLOGICAL INJURY
USE OF A NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY
ISOLATED STAPHYLOCOCCUS-SPECIFIC SOLUBLE BINDING MOLECULE
POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN B
PEPTIDE CONSTRUCT HAVING A PROTEASE-CLEAVABLE LINKER
USE OF GGF2 TO TREAT PERIPHERAL NERVE INJURY